Clinical Trial Update: Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating tinzaparin (Innohep) for the prophylaxis of venous thromboembolism in patients with primary brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Innohep (tinzaparin)

Snippet

Sponsor: Duke University | Conditions: Primary Brain Tumor | NA | Status: COMPLETED